Inventor
SCHMEES NORBERT
DE30 patents
⚠️ This page may combine multiple inventors who share the name “SCHMEES NORBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
10 patentsUS6897224B2May 24, 2005
Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
SCHERING AG48 citations94
US7442794B2Oct 28, 2008
Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
SCHERING AG11 citations84
US7417056B2Aug 26, 2008
5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
SCHERING AG6 citations72
US7129270B2Oct 31, 2006
Nonsteroidal antiinflammatory agents
SCHERING AG8 citations72
US7109212B2Sep 19, 2006
Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
SCHERING AG3 citations62
US7166592B2Jan 23, 2007
Nonsteroidal antiinflammatory agents
SCHERING AG3 citations61
US7112584B2Sep 26, 2006
Nonsteroidal antiinflammatory agents
SCHERING AG2 citations60
US7329753B2Feb 12, 2008
Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
SCHERING AG0 citations41
US7238707B2Jul 3, 2007
Substituted pentanols, a process for their production and their use as anti-inflammatory agents
SCHERING AG0 citations41
US7408060B2Aug 5, 2008
Nonsteroidal progesterone receptor modulators
SCHERING AG0 citations39
BAYER AG
7 patentsUS11304946B2Apr 19, 2022
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
BAYER AG2 citations71
US11795164B2Oct 24, 2023
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
BAYER AG3 citations70
US11524944B2Dec 13, 2022
2-phenylpyrimidine-4-carboxamides as AHR inhibitors
BAYER AG1 citations60
US11998539B2Jun 4, 2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation
BAYER AG1 citations59
US12478621B2Nov 25, 2025
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
BAYER AG0 citations58
US11964953B2Apr 23, 2024
Substituted aminothiazoles as DGKzeta inhibitors for immune activation
BAYER AG0 citations56
US11161825B2Nov 2, 2021
4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides
BAYER AG0 citations47
BAYER SCHERING PHARMA AG
5 patentsUS7388006B2Jun 17, 2008
Non-steroidal progesting
BAYER SCHERING PHARMA AG51 citations90
US7659297B2Feb 9, 2010
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BAYER SCHERING PHARMA AG3 citations62
US7662821B2Feb 16, 2010
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BAYER SCHERING PHARMA AG1 citations52
US7638515B2Dec 29, 2009
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BAYER SCHERING PHARMA AG1 citations52
US7880042B2Feb 1, 2011
Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics
BAYER SCHERING PHARMA AG0 citations41
Bayer Pharma AG
3 patentsZENTARIS AG
2 patentsUS6790858B2Sep 14, 2004
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
ZENTARIS AG34 citations89
US7378522B2May 27, 2008
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
ZENTARIS AG0 citations49